Traditional and novel diagnostic biomarkers for acute myocardial infarction
Abstract Background Acute myocardial infarction (AMI) is a leading cause of death worldwide. The first hours of acute myocardial infarction are correlated with the highest risk of death. Therefore, early diagnosis of the infarction seriously affects the efficacy of the treatment administered to the...
Main Author: | Husam Khalil |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-12-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-022-00178-w |
Similar Items
-
Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1
by: Aleksey M. Chaulin, et al.
Published: (2020-10-01) -
Peripheral Blood MicroRNAs as Potential Biomarkers of Myocardial Damage in Acute Viral Myocarditis
by: Maria Marketou, et al.
Published: (2021-03-01) -
Combined measurements of plasma copeptin and troponin-I levels for early exclusion of acute myocardial infarction
by: Walid Omar Ahmed, et al.
Published: (2016-12-01) -
Evaluating of some heart and liver enzymes in patients with myocardial infarction in Wasit.
by: hashim hussain
Published: (2023-12-01) -
Comparison of Troponin, High-Sensitivity Troponin, and Copeptin Markers at Different Times in Patients with High-Risk Chest Pain
by: Alireza Abootalebi, et al.
Published: (2019-08-01)